{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T10:44:23Z","timestamp":1786358663265,"version":"build-2736575974"},"reference-count":44,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.ahj.2013.07.028","type":"journal-article","created":{"date-parts":[[2013,9,14]],"date-time":"2013-09-14T01:15:31Z","timestamp":1379121331000},"page":"669-675","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Dual antiplatelet therapy versus oral anticoagulation plus dual antiplatelet therapy in patients with atrial fibrillation and low-to-moderate thromboembolic risk undergoing coronary stenting: Design of the MUSICA-2 randomized trial"],"prefix":"10.1016","volume":"166","clinical-trial-number":[{"clinical-trial-number":"nct01141153","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Antonia","family":"Sambola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Bruno","family":"Montoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno Garc\u00eda","family":"del Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Llavero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 A.","family":"Barrab\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Alfonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9ctor","family":"Bueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Cequier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Serra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Zueco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manel","family":"Sabat\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriol","family":"Rodr\u00edguez-Leor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Garc\u00eda-Dorado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"123","key":"10.1016\/j.ahj.2013.07.028_bb0005","first-page":"e269","volume":"15","author":"Fuster","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2013.07.028_bb0010","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke results from the national registry of atrial fibrillation","volume":"282","author":"Gage","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2013.07.028_bb0015","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1056\/NEJM199812033392303","article-title":"Randomized trial comparing three drug regimens to prevent thrombosis following elective coronary stenting","volume":"339","author":"Leon","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2013.07.028_bb0020","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(01)05701-4","article-title":"Clopidogrel in unstable angina to prevent recurrent events trial (CURE) investigators. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study","volume":"358","author":"Mehta","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2013.07.028_bb0025","first-page":"e574","article-title":"2011 ACCF\/AHA\/SCAI Guidelines for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions","volume":"124","author":"Levine","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2013.07.028_bb0030","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1093\/eurheartj\/ehq172","volume":"31","author":"Wijns","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2013.07.028_bb0035","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ahj.2003.06.004","article-title":"Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation","volume":"147","author":"Orford","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2013.07.028_bb0040","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1093\/eurheartj\/ehl488","article-title":"Safety and efficacy of combined antiplatelet warfarin therapy after coronary stenting","volume":"28","author":"Karjalainen","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2013.07.028_bb0045","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1093\/eurheartj\/ehm186","article-title":"Combining warfarin and antiplatelet therapy after coronary stenting in the Global Registry of Acute Coronary Events: is it safe and effective to use just one antiplatelet agent?","volume":"28","author":"Nguyen","year":"2007","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.ahj.2013.07.028_bb0050","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1378\/chest.08-0350","article-title":"Increased major bleeding complications related to triple antithrombotic therapy usage in patients with atrial fibrillation undergoing percutaneous coronary artery stenting","volume":"134","author":"Manzano-Fernandez","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.ahj.2013.07.028_bb0055","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jacc.2007.11.035","article-title":"Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation","volume":"51","author":"Ruiz-Nodar","year":"2008","journal-title":"JACC"},{"key":"10.1016\/j.ahj.2013.07.028_bb0060","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1136\/hrt.2009.167064","article-title":"Therapeutic strategies after coronary stenting in chronically anticoagulated patients: the MUSICA study","volume":"95","author":"Sambola","year":"2009","journal-title":"Heart"},{"key":"10.1016\/j.ahj.2013.07.028_bb0065","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/archinternmed.2010.271","article-title":"Risk of bleeding with single, dual or triple therapy with warfarin, aspirin and clopidogrel in patients with atrial fibrillation","volume":"170","author":"Hansen","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2013.07.028_bb0070","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijcard.2010.11.019","article-title":"Meta-analysis of the combination of warfarin and dual antiplatelet therapy after coronary stenting in patients with indications for chronic oral anticoagulation","volume":"148","author":"Gao","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ahj.2013.07.028_bb0075","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.4244\/EIJV6I9A183","article-title":"Efficacy and safety of clopidogrel after PCI with stenting in patients on oral anticoagulants with acute coronary syndrome","volume":"6","author":"Persson","year":"2011","journal-title":"EuroIntervention"},{"issue":"10","key":"10.1016\/j.ahj.2013.07.028_bb0080","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1161\/CIRCULATIONAHA.112.114967","article-title":"Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nation-wide cohort study","volume":"126","author":"Lamberts","year":"2012","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ahj.2013.07.028_bb0085","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.amjcard.2011.10.046","volume":"109","author":"Nikolsky","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2013.07.028_bb0090","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.amjcard.2011.10.004","article-title":"Melbourne impact of periprocedural atrial fibrillation on short-term clinical outcomes following percutaneous coronary intervention. Interventional Group Investigators","volume":"109","author":"Chan","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2013.07.028_bb0095","doi-asserted-by":"crossref","first-page":"672","DOI":"10.4244\/EIJV8I6A105","article-title":"Triple antithrombotic therapy following an acute coronary syndrome: prevalence, outcomes and prognostic utility of the HAS-BLED score","volume":"8","author":"Smith","year":"2012","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ahj.2013.07.028_bb0100","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3109\/07853890.2010.543919","article-title":"Long-term safety of drug-eluting stents in patients on warfarin treatment","volume":"44","author":"Annala","year":"2012","journal-title":"Ann Med"},{"issue":"2","key":"10.1016\/j.ahj.2013.07.028_bb0105","first-page":"204","article-title":"Risk of bleeding on triple antithrombotic therapy after percutaneous coronary intervention\/stenting: a systematic review and meta-analysis","volume":"29","author":"Andrade","year":"2013","journal-title":"Can J Cardiol"},{"issue":"2","key":"10.1016\/j.ahj.2013.07.028_bb0110","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s11239-012-0790-y","article-title":"Major bleeding in patients undergoing PCI and triple or dual antithrombotic therapy: a parallel-cohort study","volume":"35","author":"Denas","year":"2013","journal-title":"J Thromb Thrombolysis"},{"issue":"2","key":"10.1016\/j.ahj.2013.07.028_bb0115","first-page":"213","article-title":"Antithrombotic therapy after coronary stenting in patients with nonvalvular atrial fibrillation","volume":"29","author":"Ho","year":"2013","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.ahj.2013.07.028_bb0120","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(12)62177-1","article-title":"Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial","volume":"381","author":"Dewilde","year":"2013","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.ahj.2013.07.028_bb0125","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","article-title":"Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery","volume":"31","author":"Camm","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2013.07.028_bb0130","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(06)68845-4","article-title":"Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbersatan for prevention of vascular events (ACTIVE W): a randomised controlled trial","volume":"367","author":"Connolly","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2013.07.028_bb0135","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1161\/CIRCINTERVENTIONS.111.965186","article-title":"Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: a North American perspective: executive summary","volume":"4","author":"Faxon","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2013.07.028_bb0140","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.amjcard.2005.06.056","article-title":"Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes","volume":"96","author":"Rao","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2013.07.028_bb0145","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.jacc.2007.02.027","article-title":"Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial","volume":"49","author":"Manoukian","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2013.07.028_bb0150","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1016\/j.jacc.2009.09.076","article-title":"A risk score to predict bleeding in patients with acute coronary syndromes","volume":"55","author":"Mehran","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.ahj.2013.07.028_bb0155","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1161\/CIRCULATIONAHA.106.612812","article-title":"Adverse impact of bleeding on prognosis in patients with acute coronary syndromes","volume":"114","author":"Eikelboom","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2013.07.028_bb0160","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/j.jacc.2008.12.073","article-title":"Bleeding, blood transfusion, and increased mortality after percutaneous coronary intervention: implications for contemporary practice","volume":"53","author":"Doyle","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2013.07.028_bb0165","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/S0140-6736(09)61751-7","article-title":"Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data","volume":"374","author":"S\u00f8rensen","year":"2009","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.ahj.2013.07.028_bb0170","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1161\/CIRCULATIONAHA.109.924944","article-title":"Triple antithrombotic therapy in patients with atrial fibrillation and coronary artery stents","volume":"121","author":"Paikin","year":"2010","journal-title":"Circulation"},{"issue":"9872","key":"10.1016\/j.ahj.2013.07.028_bb0175","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S0140-6736(13)60054-9","article-title":"Dual or single antiplatelet therapy with anticoagulation?","volume":"381","author":"Fox","year":"2013","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.ahj.2013.07.028_bb0180","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1161\/CIRCULATIONAHA.108.191768","volume":"119","author":"Patel","year":"2009","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.ahj.2013.07.028_bb0185","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1093\/eurheartj\/ehq277","volume":"31","author":"Wijns","year":"2010","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.ahj.2013.07.028_bb0190","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1161\/STROKEAHA.112.665331","article-title":"Risk factors for intracranial hemorrhage in acute ischemic stroke patients treated with recombinant tissue plasminogen activator: a systematic review and meta-analysis of 55 studies","volume":"43","author":"Whiteley","year":"2012","journal-title":"Stroke"},{"issue":"16","key":"10.1016\/j.ahj.2013.07.028_bb0195","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1161\/CIR.0b013e31826e1058","article-title":"Third universal definition of myocardial infarction","volume":"126","author":"Thygesen","year":"2012","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.ahj.2013.07.028_bb0200","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Academic Research Consortium. Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2013.07.028_bb0205","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1161\/01.CIR.76.1.142","article-title":"Thrombolysis in Myocardial Infarction (TIMI) trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge","volume":"76","author":"Chesebro","year":"1987","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.ahj.2013.07.028_bb0210","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1056\/NEJM199805213382102","volume":"338","year":"1998","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ahj.2013.07.028_bb0215","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.ahj.2012.01.017","volume":"163","author":"Fosbol","year":"2012","journal-title":"Am Heart J"},{"issue":"18","key":"10.1016\/j.ahj.2013.07.028_bb0220","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1161\/CIR.0b013e318290826d","volume":"127","author":"Anderson","year":"2013","journal-title":"Circulation"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870313005140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870313005140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:51:36Z","timestamp":1757569896000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870313005140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0002870313005140"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2013.07.028","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual antiplatelet therapy versus oral anticoagulation plus dual antiplatelet therapy in patients with atrial fibrillation and low-to-moderate thromboembolic risk undergoing coronary stenting: Design of the MUSICA-2 randomized trial","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2013.07.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}